Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,542.00    33.00 (1.32%)
Bid:
2,526.00
Ask:
2,528.00
Spread: 2.00 (0.079%)
Market Cap: £22.66b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Directorate Change

12 Feb 2025 07:00

RNS Number : 7574W
Experian plc
12 February 2025
 

Experian plc

 

 

Directorate Change

 

 

12 February 2025 - Experian plc, the global data and technology company, announces the appointment of a new independent Non-Executive Director to the Board of Experian plc, effective from 1 March 2025.

 

Eduardo Vassimon, a Brazilian national, is Chair of Votorantim S.A., a privately-owned investment holding company. With more than 35 years' prior experience in financial services, Eduardo has combined senior executive roles at Itaú Unibanco (where he was the Chief Executive Officer of Banco Itaú BBA and led the Wholesale Bank for the Group, having previously been the Group Chief Financial Officer and Group Chief Risk Officer) with more entrepreneurial activities/ventures, including at Fundo Pitanga. He was previously a director of B3, one of the world's largest financial market infrastructure companies, where he chaired the risk and financial committee, and of TOTVS S.A., Brazil's largest technology company, where he chaired the nomination and corporate governance committee.

 

Mike Rogers, Chair of Experian, commented:

 

"I am delighted to welcome Eduardo to the Experian Board. His appointment is another strong addition for us, bringing his significant experience from the financial services sector, Experian's largest vertical, as well as his deep knowledge of the Brazilian market. Eduardo also adds further financial expertise. We are excited to welcome Eduardo to the Experian Board, and we look forward to working with him."

 

The Company confirms, save for Eduardo Vassimon's previous directorships of B3 and TOTVS S.A., that there are no details to be disclosed under UK Listing Rule 6.4.8R, paragraphs (1) to (6) in respect of his appointment.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4220

Nick Jones Media queries +44 (0)79 7673 4702

 

Teneo

Graeme Wilson and Louise Male +44 (0)20 7353 4200

 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATBMLTMTTBBFA
Date   Source Headline
19th May 202112:20 pmRNSShare repurchases
19th May 20217:00 amRNSFull-year financial report
30th Apr 20213:19 pmRNSTotal Voting Rights
14th Apr 20219:15 amRNSAdditional Listing
31st Mar 202110:11 amRNSTotal Voting Rights
24th Mar 20219:00 amRNSDirectorate Change
19th Mar 202110:57 amRNSBlock listing Interim Review
18th Mar 20214:40 pmRNSDirector Declaration
10th Mar 20219:15 amRNSAdditional Listing
26th Feb 20212:26 pmRNSTotal Voting Rights
17th Feb 202110:53 amRNSBlock listing
8th Feb 20217:00 amRNSResponse to media speculation in Brazil
29th Jan 20213:03 pmRNSTotal Voting Rights
19th Jan 20217:00 amRNSExperian plc, Trading update, third quarter
15th Jan 20215:45 pmRNSFirst interim dividend
4th Jan 202111:16 amRNSTotal Voting Rights
18th Dec 202011:00 amRNSElections for first interim dividend
9th Dec 202010:00 amRNSAdditional Listing
30th Nov 20203:40 pmRNSTotal Voting Rights
26th Nov 202011:30 amRNSLong-Term Incentive Plans – Performance Measures
25th Nov 20209:39 amRNSAdditional Listing
17th Nov 20203:36 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSHalf-year Report
30th Oct 20203:14 pmRNSTotal Voting Rights
27th Oct 202012:32 pmRNSUK marketing services - ICO enforcement notice
21st Oct 20209:08 amRNSAdditional Listing
30th Sep 20202:17 pmRNSTotal Voting Rights
28th Sep 20206:15 pmRNSBond Issue
25th Sep 202012:30 pmRNSHolding(s) in Company
23rd Sep 202012:02 pmRNSDirector/PDMR Shareholding
18th Sep 20202:58 pmRNSBlock listing Interim Review
9th Sep 20209:22 amRNSAdditional Listing
8th Sep 20207:00 amRNSTrading update, Q2 revenue expectations revised
1st Sep 202010:25 amRNSTotal Voting Rights
28th Aug 202010:00 amRNSDirector/PDMR Shareholding
26th Aug 20209:15 amRNSAdditional Listing
19th Aug 20206:01 pmRNSExperian South Africa curtails fraud incident
19th Aug 20209:12 amRNSAdditional Listing
31st Jul 202012:55 pmRNSTotal Voting Rights
31st Jul 202012:00 pmRNSDirector/PDMR Shareholding
22nd Jul 202011:38 amRNSResult of AGM
16th Jul 20207:00 amRNSExperian PLC Trading update, first quarter
3rd Jul 20205:41 pmRNSSecond Interim Dividend
1st Jul 20202:00 pmRNSDirectorate Change
30th Jun 20202:53 pmRNSTotal Voting Rights
24th Jun 202012:25 pmRNSAdditional Listing
19th Jun 20204:40 pmRNSSecond Price Monitoring Extn
19th Jun 20204:35 pmRNSPrice Monitoring Extension
12th Jun 20202:50 pmRNSAnnual Financial Report
12th Jun 20202:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.